Company Filing History:
Years Active: 2006
Title: Martine Cerutti: Innovator in HIV Research
Introduction
Martine Cerutti is a notable inventor based in Saint Christol Lez Ales, France. She has made significant contributions to the field of HIV research, particularly through her innovative work on gp120 mutants.
Latest Patents
Martine Cerutti holds a patent for "Gp120 mutants and biological applications." This patent involves an isolated and purified human immunodeficiency virus type 1 (HIV-1) mutant gp120 envelope glycoprotein. The invention includes an amino acid mutation in position which replaces W with S, I, or F, based on the molecular clone HxBc2. She has 1 patent to her name.
Career Highlights
Martine Cerutti is affiliated with the Institut de Recherche pour le Développement (IRD), where she continues her research and development efforts. Her work focuses on advancing the understanding of HIV and its biological applications.
Collaborations
Martine collaborates with Francisco Veas, contributing to the collective knowledge and advancements in their field.
Conclusion
Martine Cerutti's innovative work in HIV research exemplifies her dedication to scientific advancement. Her contributions are vital in the ongoing fight against HIV, showcasing the importance of research and innovation in healthcare.